Advisor Partners LLC Eli Lilly & CO Transaction History

Advisor Partners LLC

$1.42 Billion
Q2 2022

A detailed history of Advisor Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisor Partners LLC holds 44,517 shares of LLY stock, worth $35.4 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

44,517

Previous 42,189 5.52%

Holding current value

$35.4 Million

Previous $12.1 Million 19.47%

% of portfolio

1.02%

Previous 0.76%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $648,883 - $761,884	2,328 Added 5.52%	44,517 $14.4 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $62,427 - $77,581	-266 Reduced 0.63%	42,189 $12.1 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $149,525 - $185,561	665 Added 1.59%	42,455 $11.7 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $98,390 - $121,083	-444 Reduced 1.05%	41,790 $9.66 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $102,010 - $131,950	565 Added 1.36%	42,234 $9.69 Million
Q1 2021 Jun 01, 2021	SELL	$164.32 - $212.72 $349,015 - $451,817	-2,124 Reduced 4.85%	41,669 $7.79 Million
Q4 2020 Feb 17, 2021	SELL	$130.46 - $172.63 $474,091 - $627,337	-3,634 Reduced 7.66%	43,793 $7.39 Million
Q3 2020 Nov 19, 2020	SELL	$146.22 - $169.13 $267,582 - $309,507	-1,830 Reduced 3.72%	47,427 $7.02 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $307,899 - $370,554	2,257 Added 4.8%	49,257 $8.09 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.38 Million - $1.7 Million	11,570 Added 32.66%	47,000 $6.52 Million
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $436,019 - $540,049	4,078 Added 13.01%	35,430 $5 Million
Q3 2019 Oct 16, 2019	BUY	$106.79 - $116.16 $86,499 - $94,089	810 Added 2.65%	31,352 $3.51 Million
Q2 2019 Jul 26, 2019	BUY	$110.79 - $129.32 $51,628 - $60,263	466 Added 1.55%	30,542 $3.38 Million
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $105,299 - $123,944	-946 Reduced 3.05%	30,076 $3.9 Million
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $531,512 - $595,454	5,019 Added 19.3%	31,022 $3.59 Million
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $76,672 - $95,827	893 Added 3.56%	26,003 $2.79 Million
Q2 2018 Jul 25, 2018	BUY	$75.7 - $86.88 $224,677 - $257,859	2,968 Added 13.4%	25,110 $2.14 Million
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $87,419 - $103,192	-1,178 Reduced 5.05%	22,142 $1.71 Million
Q4 2017 Jan 26, 2018	BUY	$81.94 - $87.89 $218,452 - $234,314	2,666 Added 12.91%	23,320 $1.99 Million
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $1.59 Million - $1.77 Million	20,654	20,654 $1.77 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Account

Advisor Partners LLC Eli Lilly & CO Transaction History